2013 ACR/ARHP Annual Meeting Archives - Page 19 of 193

Abstract Number: 2907

D1398G Variant Of Hepatocyte Growth Factor Receptor – A Potential Biomarker Of Severe Interstitial Lung Disease In African American Scleroderma Patients
Abstract Number: 505

Damage Accrual In a Single Centre Cohort Of Patients With Primary Sjögren’s Syndrome Followed Up For Over 10 Years
Abstract Number: 2896

Damage In Systemic Lupus Erythematosus Is a Potentially Modifiable Outcome: Results From The Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
Abstract Number: 535

Death Receptor 3 Increases Region-Specific, Osteoblast-Dependent Aberrant New Bone Formation In The Axial Skeleton Of Mice In a Spontaneous Model Of Ankylosing Enthesopathy
Abstract Number: 296

Declines In Levels Of Disease Activity and Physical Disability In Children With Juvenile Idiopathic Arthritis Seen In Standard Clinical Care Over The Last 25 Years
Abstract Number: 75

Decorin-Deficiency Alters Cartilage Stiffness and Attenuates The Development Of Osteoarthritis In Mice
Abstract Number: 1377

Decoy Receptor 3 Regulates the Expression of Tryptophan Hydroxylase TPH1 in Rheumatoid Synovial Fibroblasts
Abstract Number: 1628

Decreased Levels Of Splicing Factor 2 / Alternative Splicing Factor (SF2/ASF) Correlate With Lower Transcript Levels Of The RasGRP1 Normal Isoform In Lupus T Cells
Abstract Number: 1158

Decreased NK-Cell Numbers and Upregulation Of Markers Of Systemic Inflammation In Autoantibody –Positive Arthralgia Patients and Early Rheumatoid Arthritis Patients But Not In Autoantibody-Negative Rheumatoid Arthritis Patients
Abstract Number: 2072

Decreased Number Of Circulating NK Cells and Dramatic Lack Of IFN-Gamma Production In Patients With Antisynthetase Syndrome
Abstract Number: 936

Decreased Plasma Levels Of Soluble CD18 Link Leukocyte Migration and Disease Activity In Spondyloarthritis
Abstract Number: 1578

Decreased Sensitivity Of a Commercial Anti-dsDNA Assay In Patients With Moderately To Severely Active Systemic Lupus Erythematosus
Abstract Number: 1622

Deep-Sequencing Reveals Class-Specific Urinary Micrornas In Human Lupus Nephritis
Abstract Number: 35

Defective Regulatory Function Of Granzyme B-Producing B Cells In Patients With Systemic Lupus Erythematosus
Abstract Number: 2710

Deficiency Of The Protein Kinase Ataxia Telangiectasia Mutated Accelerates T Cell Aging In Rheumatoid Arthritis
Abstract Number: 1586

Defining Hand Arthritis In Systemic Lupus Erythematosus, From An Ultrasound, Magnetic Resonance Imaging and Antibody Status Perspective
Abstract Number: 2086

Defining The Prevalence and Associated Risk Factors For Calcinosis In Adult Dermatomyositis Patients
Abstract Number: 2203

DEK’s Autoantigenicity In Juvenile Idiopathic Arthritis Resides In Its C-Terminal 25 Amino Acids
Abstract Number: 186

Delay In Consultation and Starting Disease Modifying Anti-Rheumatic Drugs In Patients With Rheumatoid Arthritis In Argentina. How Early Arthritis Clinics Impact On Health Barriers?
Abstract Number: 1296

Deletion Of RBP-J In a Murine Model Of Inflammatory Arthritis Reveals Pro-Inflammatory Cytokine Expression and Immunophenotypic Differences
Abstract Number: 2533

Delta Neutrophil Index As a Marker For Differential Diagnosis Between Flare and Infection In Febrile Systemic Lupus Erythematosus Patients
Abstract Number: 2905

Demethylation of ITGAL (CD11a) regulatory sequences in CD4+T lymphocytes of Systemic Sclerosis
Abstract Number: 1237

Denosumab Leads To Significantly Greater Increases In Bone Mineral Density Than Ibandronate and Risedronate In Postmenopausal Women At High Risk For Fracture Who Were Previously Treated With An Oral Bisphosphonate
Abstract Number: 556

Depletion Of The Gut Microbiota Prevents β₂-Glycoprotein I Antibody Production and Mortality In a Model Of Antiphospholipid Syndrome
Abstract Number: 1066

Depression Screening In Patients With Systemic Lupus Erythematosus From The Southeastern United States: Missing Opportunities For Early Diagnosis and Treatment
Abstract Number: 1256

Depression, Anxiety and Suicidal Thoughts In a Cohort Of Pediatric Lupus and Mixed Connective Tissue Disease Patients
Abstract Number: 2035

Description Of 142 Cases Of Relapsing Polychondritis Followed In a Single Center Since 2000
Abstract Number: 691

Descriptive Review Of Morphea Subjects From a Single Cohort Center
Abstract Number: 1567

Desensitization To Trimethoprim/Sulfamethoxazole In Systemic Lupus Erythematosus Patients : A Retrospective Cohort Study
Abstract Number: 1499

Detection Of CD4⁺CD25^lowGITR⁺ T Lymphocytes In Sjogren’s Syndrome-Interstitial Lung Disease
Abstract Number: 221

Detection Of Cerebral Microvascular Lesions In Patients With Acute Phase Neuropsychiatric Systemic Lupus Erythematosus By 7Tesla MRI
Abstract Number: 1715

Detection Of Enthesitis In Children With Enthesitis-Related Arthritis: Dolorimeter Examination Compared To Ultrasonography
Abstract Number: 1364

Detection of Latent Tuberculosis Infection in Rheumatologic Diseases Before Anti-TNFα Therapy: Tuberculin Skin Test Versus IFN-γ Assay
Abstract Number: 2206

Detection Of State-Specific RNA Transcripts In Juvenile Idiopathic Arthritis Neutrophils Using RNA Sequencing
Abstract Number: 1989

Determinants Of Functional Disability In Patients With Gout: Longitudinal Analysis From a Multicentre Observational Study Of The Italian Society For Rheumatology
Abstract Number: 1922

Determinants Of Patient Satisfaction In An Academic Rheumatology Practice
Abstract Number: 1217

Determination Of Vitamin D Level Prior To The Initiation Of Bisphosphonate Therapy
Abstract Number: 2866

Determining The Absolute Change In The Clinical Disease Activity Index (CDAI) To Define a Minimally Important Difference
Abstract Number: 1920

Determining The Vaccination Rates Of American College Of Rheumatology Recommended Vaccines Among Veterans With Rheumatoid Arthritis – A Quality Indicator
Abstract Number: 368

Detrimental Impact Of Long-Term Cumulative Burden Of Rheumatoid Arthritis (RA) Disease Severity On Cardiovascular Outcomes In RA
Abstract Number: 1662

Developing Guideline For Polymyalgia Rheumatica: Prioritisation Of Outcome Measures – Perspective Of Patients, General Practitioners and Rheumatologists
Abstract Number: 1981

Developing International Consensus Definitions Of Improvement For Adult and Juvenile Dermatomyositis and Polymyositis
Abstract Number: 984

Development and Usability Testing Of The Arthritis Health Journal: An Online Tool To Promote Self-Monitoring In People With Rheumatoid Arthritis
Abstract Number: 2555

Development and Validation Of a Questionnaire To Screen For The Presence Of Autoimmune Disease
Abstract Number: 1129

Development and Validation Of a Rapid Knee Cartilage Quantification Method
Abstract Number: 1982

Development and Validation Of Medication Assessment Tools Specific For Rheumatoid Arthritis
Abstract Number: 289

Development and Validation Of The Cutoff Values For Disease Activity States Of The Three-Item Version Of The Juvenile Arthritis Disease Activity Score
Abstract Number: 2836

Development of a Health Index in Patients With Ankylosing Spondylitis (ASAS HI) – Final Result of a Global Initiative Based On the International Classification of Functioning, Disability and Health (ICF) Guided By Assesment of Spondyloarthritis International Society (ASAS)
Abstract Number: 497

Development Of a Novel Bispecific Therapeutic For Arthritic Diseases
Abstract Number: 977

Development Of a Tool To Assess Internal Medicine Residents’ Confidence In Their Musculoskeletal Examination Skills
Abstract Number: 1288

Development Of Antibodies Specific For Carbamylated Protein Precedes Disease Onset In Mice With Collagen-Induced Arthritis
Abstract Number: 2620

Development Of De Novo Major Involvement During The Follow-Up In Behçet’s Disease
Abstract Number: 1028

Development Of Patient-Reported Outcomes Measurement Information System (PROMIS®) Gastrointestinal (GI) Symptoms Item Bank
Abstract Number: 1699

Development Of Systemic Lupus Erythamatosus Among “Possible Systemic Lupus Erythamatosus ” Patients Seen In Consultation: Long-Term Follow-Up
Abstract Number: 2212

Development Of Tools To Facilitate Shared Decision Making About Medications For Juvenile Idiopathic Arthritis – A Project Of The Pediatric Rheumatology Care and Outcomes Improvement Network
Abstract Number: 2116

Diabetes: A Risk Factor For Poor Function Outcome After Total Knee Arthroplasty
Abstract Number: 2244

Diagnostic Accuracy Of Anti-Ccp Testing For Detecting Prevalent Rheumatoid Arthritis: Results From Screening a Population Based Cohort
Abstract Number: 909

Diagnostic Autoantibody Signatures Of Rheumatoid Arthritis Patients Identified With a Bead-Based Assay Approach
Abstract Number: 309

Diagnostic Delay Of Even More Than 6 Months Contributes To Poor Radiographic and Functional Outcome In Psoriatic Arthritis
Abstract Number: 1319

Diagnostic Value Of Anti-Citrullinated Proteins Antibodies In Rheumatoid Arthritis
Abstract Number: 513

Diagnostic Value Of Labial Minor Salivary Gland Biopsy For Primary Sjögren’s Syndrome
Abstract Number: 680

Diastolic Dysfunction Amongst Autoantibody Subgroups Of Patients With Diffuse Scleroderma
Abstract Number: 34

Dichotomous Responses Of Human Systemic Lupus Erythematosus B Cell Subsets To B Cell Receptor Stimulation
Abstract Number: 1463

Dietary Impact On Treatment Results Of Methotrexate In Patients With Rheumatoid Arthritis
Abstract Number: 2271

Dietary Sodium Increases The Risk For Rheumatoid Arthritis Among Smokers – Results From a Nested Case-Control Study
Abstract Number: 2248

Difference Between The Two Versions Of Disease Activity Score Based On C-Reactive Protein and Erythrocyte Sedimentation Rate
Abstract Number: 177

Differences and Overlap Of Immunological Pathways Implicated In The Aetiology Of Anti-Citrullinated Peptide Antibody Positive and Negative Rheumatoid Arthritis
Abstract Number: 2450

Differences and Similarities Of Spondyloarthritis Classification Subgroups Defined By The Assessment Of Spondyloarthritis International Society (ASAS)
Abstract Number: 2910

Differences In Abatacept Use In Rheumatoid Arthritis Patients Across Europe: A Pan-European Database Analysis Of Abatacept In European RA Registries
Abstract Number: 2105

Differences In Spinal Mobility Measures In Relation To Disease Duration and Between Subgroups With Axial Spondyloarthritis
Abstract Number: 551

Different Cell Death Programs Contribute To Severity Of Lupus Glomerulonephritis In Males and Females
Abstract Number: 1517

Different Imaging Abnormalities Suggestive Of Spondyloarthritis Are Present In Early Axial Spondyloarthritis. Data From The DESIR Cohort
Abstract Number: 707

Different Location and Extent Of Impaired Perfusion Of The Choroid Plexus In Primary and Secondary Raynaud’s Phenomenon
Abstract Number: 411

Differential Effects of biologics On The Removal Of Amyloid Deposition Between The Kidney and Gastric Tract Of Amyloid A Amyloidosis Patients With Rheumatoid Arthritis
Abstract Number: 1379

Differential Effects Of TNF Inhibitors, Anti-IL-6 Receptor Antibody and CTLA4-Ig On Human Monocytes
Abstract Number: 565

Differential Efficacy Of Human Mesenchymal Stem Cells On Disease In Murine Lupus Based On Source Of Origin
Abstract Number: 1623

Differential Methylation Of Interferon-Related Genes Is Associated With Anti-dsDNA Autoantibody Production In Systemic Lupus Erythematosus
Abstract Number: 1886

Differential Methylation Related To Response To Etanercept In Patients With Rheumatoid Arthritis
Abstract Number: 1150

Differential Regulation Of IL-10 and Dusp1 Production By Kinases In The p38 MAPK Pathway
Abstract Number: 28

Differentiation, Activation, and Autoreactivity Of CD11c+ B Cells (ABCs)
Abstract Number: 110

Differing Disease Expression In Latin American Mestizo and Spanish Caucasian Patients With Rheumatoid Arthritis With The Same Access To Healthcare and Antirheumatic Treatment
Abstract Number: 213

Digital Tomosynthesis for Measurement of Bone Erosion in Gout: Comparison With Computed Tomography
Abstract Number: 1400

Dipeptidyl Peptidase IV (DPP-IV, CD26) Levels In Patients With Rheumatoid Arthritis Treated With Biologic Therapies and Correlation With The Activity Of The Disease
Abstract Number: 2658

Dipeptidyl Peptidase-4 Inhibitors In Type 2 Diabetes May Reduce The Risk Of Autoimmune Diseases
Abstract Number: 1769

Direct and Indirect Costs For Patients With Systemic Lupus Erythematosus In National Cohorts In Sweden
Abstract Number: 124

Disability In Fibromyalgia Is Associated With Greater Self-Reported Symptoms and Functional Impairment
Abstract Number: 2367

Discontinuation Of Biological Therapy Due To Adverse Drug Reactions In Rheumatoid Arthritis Patients: 12 Years Follow-Up
Abstract Number: 1425

Discontinuation Of Tumor Necrosis Factor Inhibitors In Rheumatoid Arthritis Patients In Low Disease Activity: Persistent Benefits
Abstract Number: 1055

Discontinuation Rates In Patients With RA Of Triple Disease Modifying Antirheumatic Therapy
Abstract Number: 1472

Discontinuation Rates Of Tocilizumab Therapy In Rheumatoid Arthritis Patients In a Nonacademic Clinical Setting
Abstract Number: 197

Discordance Of Patient-Physician Assessments Of General Health In a US Hispanic Population With Rheumatoid Arthritis
Abstract Number: 1427

Discovery and Characterization Of ABT-122, An Anti-TNF/IL-17 DVD-Ig™ Molecule As a Potential Therapeutic Candidate For Rheumatoid Arthritis
Abstract Number: 1491

Discovery and Validation Of Novel Micrornas In Minor Salivary Glands Of Sjögren’s Syndrome Patients
Abstract Number: 1832

Discovery of MicroRNAs in the Regulation of Inflammation and Bone Erosion in Rheumatoid Arthritis
Abstract Number: 2416

Discovery Of Novel Biomarkers In Rheumatoid Urine : Significance Of Urinary CD14
Abstract Number: 1326

Discriminative Metabolite Profiling Of Synovial Fluid In Rheumatoid Arthritis Compared To Osteoarthritis
Abstract Number: 2401

Disease Activity (DAS-28CRP) In Rheumatoid Arthritis Correlates With Synovial Expression Of Tumor-Associated and IL-6-Dependent Genes
Abstract Number: 2541

Disease Activity Does Not Improve Significantly In One System and Worsen In Another System
Abstract Number: 1510

Disease Activity In Male Smokers Has A >10-Fold Amplified Effect On Radiographic Damage In Comparison With Female NON-Smokers In Ankylosing Spondylitis
Abstract Number: 2318

Disease Activity in Moderate and Severe Rheumatoid Arthritis At Discontinuation in 10-Year Open-Label Extension Studies With Etanercept
Abstract Number: 422

Disease Activity In Rheumatoid Arthritis Is Associated With Abnormal Left Ventricular Geometry
Abstract Number: 2447

Disease Activity Is Associated With Development Of Inflammatory Bowel Disease In Ankylosing Spondylitis: 12-Year Results From OASIS
Abstract Number: 1356

Disease Activity Of Rheumatoid Arthritis Is Influenced By Seasonal Change, As Analyzed Based On a Nationwide Japanese Cohort Database
Abstract Number: 2299

Disease Activity Scoring: Comparing Patient and Physician Global Assessment Of Disease Activity In Rhumatoid Arthritis Patients Starting a First Biologic Agent
Abstract Number: 354

Disease Burden Among Patients With Psoriatic Arthritis Who Have Experienced First Line Tumor Necrosis Factor Inhibitor Regimen Failure In The European Union
Abstract Number: 2472

Disease Burden Is Similar Between Non-Radiographic Axial Spondyloarthritis and Ankylosing Spondylitis and Independent Of Gender Influences
Abstract Number: 2811

Disease Characteristics and Treatment Patterns In US Veterans With Rheumatoid Arthritis and Concomitant Hepatitis C Infection
Abstract Number: 2677

Disease Progression Into Adulthood In Patients With Juvenile Idiopathic Arthritis – a Longitudinal 30 Year Follow-Up Study
Abstract Number: 1012

Disease Severity, Quality Of Life, and Productivity Loss Among Patients With Ankylosing Spondylitis In Germany
Abstract Number: 610

Disease Specific Quality Of Life Domains Are Impaired In Patients With Lupus Nephritis?
Abstract Number: 2820

Disease-Regulated Local Interleukin-10 Gene Therapy Diminishes Synovitis and Articular Cartilage Damage In Experimental Arthritis
Abstract Number: 1713

Disparity In Biologic Therapy In Ethnic Minorities With Rheumatoid Arthritis: Can It All Be Due To Lack Of Access To Drug?
Abstract Number: 2066

Distinct Arthropaties In Patients With Anti-Aminoacyl tRNA Synthetase Antibodies: Utility Of Autoantibody Profiles In Discrimination
Abstract Number: 1142

Distinct Pathways Of Ly6C^hi Monocyte Development Identified By a Novel Dual-Reporter Murine Myeloid Progenitor Cell Line
Abstract Number: 2774

Distinct Role Of Plasmacytoid Dendritic Cells and Mast Cells In The Pathogenesis Of Sjӧgren’s Syndrome
Abstract Number: 492

Distinction Between Glucocorticoid-Responders and Non-Responders In Rheumatoid Arthritis: A New Role For Endoplasmic Reticulum Aminopeptidase 2
Abstract Number: 2025

Distinctive Expression Profiles Of Long Intergenic Non-Coding RNA Between Polymyalgia Rheumatica and Rheumatoid Arthritis Might Contains Helpful Suggestions For Understanding and Discriminating These Diseases
Abstract Number: 665

DNA hypermethylation of Forkhead box protein 3 (FOXP3) locus leads to quantitative defects of regulatory T cells in systemic sclerosis
Abstract Number: 655

DNA Methylation and Systemic Sclerosis
Abstract Number: 1496

DNA Methylation In Six Cell and Tissue Types In Sjögren’s Syndrome Reveals Distinct Patterns Across Samples and Clustering Based On Disease Status
Abstract Number: 1717

Do Bone Marrow Edema (BME) Lesions In The Sacroiliac Joint (SIJ) Change Into Fatty Lesions Over a 3-Month Period In Patients With Axial Spondyloarthritis (axSpA)?
Abstract Number: 2094

Do Exercise Interventions For Total Hip Arthroplasty Have Therapeutic Validity? A Sensitivity Analysis Of Trials Included In a Cochrane Systematic Review
Abstract Number: 2139

Do Hyaluronic Acid Injections Delay Total Knee Replacement Surgery?
Abstract Number: 2158

Do Numbers Make a Difference?
Abstract Number: 1536

Do Patients With Ankylosing Spondylitis Have An Excess Prevalence Of Chronic Widespread PAIN?: Results From The Scotland and Ireland Registry For Ankylosing Spondylitis (SIRAS) and The Musician Study
Abstract Number: 1912

Do Persons With SLE In Poverty Rate Interactions With Providers and Health Plans Differently?
Abstract Number: 2441

Do Postural Deformities In Patients With Ankylosing Spondylitis Cause Balance Problems?
Abstract Number: 847

Do Rheumatologists (and Other Specialists) Practice What We Preach? A Study Of Serology Ordering Patterns With Attention To Subserologies When The Antinuclear Antibody By Enzyme Linked Immunosorbent Assay Is Negative; And The Clinical Significance Of These Positive Subserology Results
Abstract Number: 1306

Do Sustained Clinical Remission and Sustained Low Disease Activity Equally Predict Functional Status In Early Rheumatoid Arthritis?
Abstract Number: 1807

Do We Know How and When To Taper and Stop In Immunosuppressants In Lupus Patients?
Abstract Number: 871

Do We Need To Lower The Cut Point Of The 2010 ACR/EULAR Classification Criteria For Diagnosing Rheumatoid Arthritis?!
Abstract Number: 1372

Do We Really Identify Latent Tuberculosis? Comparison Of The Performance Of Tuberculin Skin Test and Interferon Gamma Release Assay Before Biologics: A Systematic Review and Meta-Analysis
Abstract Number: 2259

Does a Ratingen Score Of ≥ 3 At Disease Onset Define RA In ACR/EULAR 2010 Criteria Negative Patients?
Abstract Number: 1787

Does Age At Disease Onset Influence Disease Activity and Function In Rheumatoid Arthritis Patients? Results From The Ontario Best Practices Research Initiative (OBRI) Registry
Abstract Number: 997

Does Biologic Treatment For Rheumatoid Arthritis Offset Health Care Costs In Patients With Rheumatoid Arthritis? An Instrumental Variable Approach Using Administrative Data
Abstract Number: 2670

Does Change In Femorotibial Cartilage Thickness Differ Between Acutely Anterior-Cruciate Ligament Injured Knees Treated With and Without Reconstructive Surgery
Abstract Number: 398

Does Elevated Disease Activity Or Medication Use Influence The Body Composition Of The Prepubertal Offspring In Pregnant Women With Rheumatoid Arthritis?
Abstract Number: 397

Does Elevated Disease Activity Or Medication Use Influence The Bone Density Of The Prepubertal Offspring In Pregnant Women With Rheumatoid Arthritis?
Abstract Number: 1958

Does Evaluation Of Hand Bone Loss By Digital x-Ray Radiogrammetry Within The First 3 Months After Diagnosis Of Rheumatoid Arthrits Identify Patients At Risk For Radiological Progression?
Abstract Number: 1668

Does Fibrinogen Have a Role In The Assessment Of Patients With Giant Cell Arteritis?
Abstract Number: 1757

Does Foot Pain Mediate The Effect Of Knee Osteoarthritis and Risk Of Indoor and Outdoor Falls In Older Men and Women?
Abstract Number: 2136

Does Functional Gain and Pain Relief After TKR and THR Differ By Patient Obese Status?
Abstract Number: 490

Does Low Disease Activity At Six Months Predict Remission At 12 Months In Rheumatoid Arthritis Patients Treated With Biologics In a Real–World Setting?
Abstract Number: 2034

Does Mixed Connective Tissue Disease Or Sharp’s Syndrome Really Exist?
Abstract Number: 515

Does Multiplex Flow Immunoassay Underdetect SSA and SSB Antibodies? An Evaluation Of The Sjogren’s International Collaborative Clinical Alliance (SICCA) Cohort
Abstract Number: 2580

Does Mycophenolate Mofetil (MMF) Have An Effect On Pulmonary Hemodynamics? Observations From The Pulmonary Hypertension Assessment and Recognition Of Outcomes In Scleroderma (PHAROS) Cohort
Abstract Number: 1359

Does Rheumatoid Arthritis Disease Activity Correlate With Weather Conditions?
Abstract Number: 2276

Does Socioeconomic Status Affect Outcomes In Early Rheumatoid Arthritis? Data From An Inception Cohort
Abstract Number: 191

Does Specific Joint Involvement In Rheumatoid Arthritis Patients Predict Patient Reported Outcomes? Implications For Clinical Practice
Abstract Number: 1722

Does Starting Allopurinol Prolong Acute Treated Gout?
Abstract Number: 1688

Does The Treatment With Anti-Coagulants and Anti-Platelets Protect Giant Cell Arteritis Patients From Visual Manifestations?
Abstract Number: 9

Domain 1 Is The Main Specificity Of Anti-β₂glycoprotein I Antibodies In Systemic Autoimmune Diseases
Abstract Number: 1007

Dose Of Corticosteroid, Risk Of Adverse Events and Healthcare Resource Utilization In Systemic Lupus Erythematosus
Abstract Number: 2327

Dose Reduction Of Tocilizumab In Rheumatoid Arthritis Patients With Low Disease Activity Is Feasible
Abstract Number: 724

Dose-Dependent Suppression Of Cytokine Production From T Cells By a Novel Phosphoinositide 3-Kinase Delta Inhibitor
Abstract Number: 2800

Dose-Response Effects Of Denosumab, a Novel Subcutaneous RANKL Inhibitor, On The Progression Of Bone Erosion In Japanese Patients With Rheumatoid Arthritis Treated With Methotrexate: Results Of Phase II DRIVE Study – A Twelve Month Placebo Controlled, Randomized, Double Blind Study
Abstract Number: 481

Down-Titration of Biological Therapies In Rheumatoid Arthritis In Daily Clinical Practice
Abstract Number: 59

Downregulated Forkhead-Box Class O Transcription Factors Attenuate Oxidative Stress Resistance In Human Chondrocytes
Abstract Number: 2707

Downregulation Of KLF5 and Fli1 Cooperatively Contribute To Distinct Manifestations Of Systemic Sclerosis In Vitro and In Vivo
Abstract Number: 2089

Downregulation Of Mir-10a Is Associated With Increased Von Willebrand Factor Antigen, Disease Activity Score and Earlier Diagnosis In Children With Untreated Juvenile Dermatomyositis
Abstract Number: 796

Drug Exposure Limitations of Oral Methotrexate (MTX) At Doses >15mgs May be Overcome By Using a Subcutaneous MTX Auto-Injector in Patients With Rheumatoid Arthritis (RA)
Abstract Number: 1346

Drug Free Holiday In Patients With Rheumatoid Arthritis (RA): patients’ Opinion
Abstract Number: 1448

Drug Retention Rates Of Biologic Monotherapies For Patients With Rheumatoid Arthritis In Daily Clinical Practice; Using Multicenter Registry In Japan
Abstract Number: 1514

Drug Survival In Patients Receiving Golimumab Treatment 2010-2013. Results From The Swedish Rheumatology Quality Register
Abstract Number: 2354

Drug Survival Rates Of Anti-Tumor Necrosis Factor Therapies In Patients With Rheumatoid Arthritis and Ankylosing Spondylitis
Abstract Number: 1558

Drug Trends In Psoriatic Arthritis
Abstract Number: 1580

Drug-Resistant Bloodstream Infections In Systemic Lupus Erythematosus Patients: A Clinical Perspective
Abstract Number: 948

Dual Neutralization Of TNF and IL-17 Provides Greater Efficacy In Collagen Induced Arthritis Through Regulation Of a Gene Transcription Program That Includes CXCL1 and CXCL5
Abstract Number: 212

Dual-Energy Computed Tomography for Monitoring of Urate Deposition in Tophaceous Gout: A Prospective Longitudinal Study Examining Sensitivity to Change
Abstract Number: 107

Duration Of Symptoms Before Diagnosis In Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Abstract Number: 2609

Dutch Translation and Validation Of The University of California, Los Angeles scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument 2.0
Abstract Number: 1835

Dynamic Visualization Of Monocyte Migration In 3D Synovial Micromass Tissue Cultures
Abstract Number: 175

Dynamics Of The Inflammatory Response In Rheumatoid Arthritis Patients Following Traumatic Injury: Insights From In Vivo,In Silico, and Single Nucleotide Polymorphism Studies